Circadian Rhythm Sleep Treatment Market

Circadian Rhythm Sleep Treatment Market Outlook (2024 to 2034)

The global circadian rhythm sleep treatment market size is estimated at US$ 784.7 million in 2024 and is projected to reach a size of US$ 1.23 billion by the end of 2034, expanding at a CAGR of 4.7% between 2024 and 2034.

Circadian rhythm sleep disruption is the term used to describe a disturbance in sleep patterns that impacts the body's fundamental processes. Restlessness, extreme tiredness, and sleeplessness are a few signs of this sleep condition.

Circadian rhythms, which are commonly referred to as the biological clock, regulate various daily functions such as body temperature, attentiveness, hormone release, and sleep patterns.

When an individual's circadian rhythm is not in harmony with their environment, they experience difficulty falling asleep, which affects their quality of sleep. If the sleep-wake cycle is disturbed to the point where it interferes with daily activities, then it is termed a circadian rhythm disruption. Any changes to the suprachiasmatic nucleus region cause memory loss or sleeplessness. In addition, delayed sleep phase disorder is a circadian rhythm sleep condition linked to problems falling asleep, wherein, the sleep event begins later than intended.

Several illnesses have been linked to disturbances in the circadian rhythm. Urbanization and industrialization have collectively increased the risk of chronic diseases among corporate workers.

Report Attributes	Details
Circadian Rhythm Sleep Treatment Market Size (2024E)	US$ 784.7 Million
Forecasted Market Value (2034F)	US$ 1.23 Billion
Global Market Growth Rate (2024 to 2034)	4.7% CAGR
North America Market Share (2034F)	35.6%
East Asia Market Growth Rate (2024 to 2034)	5.6% CAGR
Institutional Segment Market Share (2024E)	78.8%
Delayed Sleep Phase Syndrome Segment Market Share (2024E)	50.7%
Key Companies Profiled	Vanda Pharmaceuticals, Inc. Akeda Pharmaceutical Company LimitedIdorsia Pharmaceuticals Ltd. VU University Medical CenterNeuraxpharm The Sunbox Company

What are the Factors Driving Global Circadian Rhythm Sleep Treatment Market Expansion?

“Focus on Addressing Interplay Between Depression and Insomnia and Consequent Financial Impact”

Due to the severe burden illnesses related to circadian rhythm disruption place on society overall, including high rates of morbidity and mortality as well as financial consequences, society is forced to depend more on treatments for sleep disorders, which is driving the global circadian rhythm sleep treatment market growth.

• According to the World Health Organization (WHO), depression is a widespread illness that impacts more than 264 million individuals and eventually results in sleep disturbances or other significant health issues. The prevalence of depression is one of the primary drivers in the market for sleep disorders.

An increasing amount of data, mostly from Western countries, shows that the average length of sleep is decreasing and that the prevalence of insomnia is rising. More than 20% of people have insomnia, according to national surveys done in the United States and Canada. This percentage is consistent with the frequent occurrence of short sleep duration in developed countries.

“Public Health Initiatives Promoting Awareness about Circadian Rhythm Sleep Disorders”

The rising awareness of circadian rhythm sleep disorders can be attributed to increased public health initiatives, education campaigns, and the dissemination of information through digital platforms. Increasing knowledge and symptoms of CRSDs among patients and medical professionals is another factor contributing to the rise in diagnosis rates. As diagnosis becomes more readily available, more people are looking for appropriate treatment and management alternatives, which is driving market expansion.

Increased emphasis on diagnosis and awareness is drawing funding for research and development, opening the door for cutting-edge technologies and treatment approaches. As a result, improved healthcare practices and a greater comprehension of the relationship between heart health and sleep are driving market growth.

What are the Issues Related to Circadian Rhythm Sleep Treatment?

“Limited Awareness about Circadian Rhythm Sleep Disorders Entailing Misdiagnosis”

The lack of understanding about sleep disorders associated with the circadian rhythm is a significant obstacle to market growth. It is possible that neither the general public nor medical professionals are aware of the symptoms or that they are mistaken for other ailments. Furthermore, this misinformation could lead to delayed treatment and an inaccurate diagnosis, which is expected to hinder market growth.

Limited awareness affects many aspects of the market, including difficulties in obtaining funds for research and development in this domain and misdiagnosis. Patients often do not know about the possible hazards of sleep gummies or the availability of efficient treatment choices, which reduces demand for existing therapies and impedes market expansion.

Closing the knowledge gap is essential for stimulating innovation in treatments that combine sleep aid supplements and cardiology, as well as for enhancing patient outcomes and market growth.

“High Treatment Cost and Safety Concerns over Circadian Rhythm Lighting”

Adoption of treatments such as circadian rhythm lighting is projected to be hindered by elevated costs and increasing concerns about potential negative effects on eyesight. Industry players encounter challenges stemming from limited research and uncertainties regarding impulsive behavior and weight gain linked to prolonged use of circadian rhythm lighting.

Specific dangers and considerations are tied to the application of circadian rhythm lighting as a therapeutic approach in circadian rhythm sleep treatment. Despite the intention of this innovative strategy to regulate the body's internal clock and possibly improve cardiac health and sleep quality, careful attention must be given to address potential hazards and hurdles.

Country-wise Insights

Throughout the forecast period, North America is projected to hold a major revenue share and lead the worldwide market. The aging population's growing need, technological advancements, and a healthcare system that focuses on addressing cardiac diseases connected to sleep effectively are driving the growth of the circadian rhythm sleep treatment market.

What’s Consolidating the Position of the United States on the Global Platform?

“Robust Healthcare Infrastructure and Technological Advancements in Therapy”

Attribute	United States
Market Value (2024E)	US$ 238 Million
Growth Rate (2024 to 2034)	5% CAGR
Projected Value (2034F)	US$ 389 Million

Growing number of mental health issues resulting from sleep disorders in the country, coupled with the improved healthcare infrastructure and awareness of the detrimental impacts of sleep disorders, is driving market expansion.

The United States market is growing quickly as a result of increased awareness and sophisticated healthcare systems. Demand for circadian rhythm sleep treatment is being driven by factors such as changes in lifestyle, a rise in the prevalence of sleep disorders, and greater awareness of the effects of circadian rhythms on general health. The market is growing because of innovations in therapy, such as wearable technology and light-based treatments.

Why is the Market in Japan Expanding Steadily?

“Healthcare Policies Prioritizing Sleep Disorder Management amid Increase in Stress Levels”

Attribute	Japan
Market Value (2024E)	US$ 60 Million
Growth Rate (2024 to 2034)	4.8% CAGR
Projected Value (2034F)	US$ 96 Million

The circadian rhythm sleep treatment market size in Japan is driven by the awareness of the significance of sleep health and its relationship to cardiovascular health. The management of sleep disorders associated with heart health is becoming an integral part of preventive care, with government policies and healthcare programs increasingly incorporating such measures.

Sleep disorders are worsened by the work culture and lifestyle in Japan, which are characterized by lengthy workdays and high levels of stress. The necessity for efficient circadian rhythm sleep therapies is fueled by this social factor.

The market in Japan is transforming due to certain cultural, demographic, and medical system aspects. With its increasingly aging population and sophisticated healthcare system, Japan offers opportunities as well as challenges in this specialized medical field.

Category-wise Insights

The introduction of circadian rhythm sleep treatment devices into the market signifies a fusion of advanced technology and robust healthcare infrastructure, providing novel, non-invasive treatment options that are simple to incorporate into everyday life. A significantly delayed sleep-wake cycle is the symptom of delayed sleep phase syndrome (DSPS), a circadian rhythm sleep disorder.

Which Treatment Accounts for Significant Revenue Streams?

“Device-based Therapies Becoming Popular as Technology-driven Approach for Treating Sleep Disorders”

Attribute	Devices
Segment Value (2024E)	US$ 528.3 Million
Growth Rate (2024 to 2034)	4.6% CAGR
Projected Value (2034F)	US$ 831.6 Billion

Adoption of device-based therapies is a major circadian rhythm sleep treatment market trend, which represents a big change towards cutting-edge, tech-driven approaches to treating sleep problems. Sleep masks are becoming essential instruments in the treatment of a variety of sleep-related problems since they are made to realign and support the body's natural circadian cycles.

The elements produce light that replicates sunlight, which aids in resetting the body's circadian clock. They are especially helpful for diseases like SAD (seasonal affective disorder) and other depressions associated with irregularities in the circadian cycle.

Sleep aid devices that track sleep patterns and offer insights into the sleep-wake cycle include fitness trackers and smartwatches. Even features to gently urge a return to regular sleep patterns are included in some more advanced models.

Which Disorder Segment Accounts for a Leading Market Share?

"High Demand for Treatment Targeting Delayed Sleep-Wake Phase Disorder”

Attribute	Delayed Sleep Phase Syndrome
Segment Value (2024E)	US$ 397.5 Million
Growth Rate (2024 to 2034)	5.1% CAGR
Projected Value (2034F)	US$ 650.6 Billion

Due to neuron dysfunction in older adults, teenagers, and comorbidities, the delayed sleep-wake phase syndrome segment holds a significant circadian rhythm sleep treatment market share in 2024. A person experiencing delayed sleep-wake phase disorder (DSWPD) typically goes to bed two or more hours later than what is considered normal or socially acceptable. The inability to fall asleep at the intended hour is the root of this issue. One common complaint among the elderly is lack of sleep.

• In a National Institute on Aging survey of more than 9,000 adults 65 years of age and older, more than half of the men and women reported having at least one ongoing sleep problem.

The younger generation's sleep problems can show up in many different ways, such as difficulty falling and staying asleep.

• The National Library of Medicine reports that the most common circadian rhythm sleep issue, contributing to the segment's rise, is delayed sleep phase disorder, which affects 0.17% of adults in the United States and 7% to 16% percent of adolescents.

Competitive Landscape

To satisfy more customers, industry leaders are bringing new and inventive items to the market. To increase their consumer base and strengthen their market position, multinational corporations are expanding into new markets in developing countries.

• Japanese pharmaceutical company Eisai Co. announced in December 2019 that the United States Food and Drug Administration authorized Dayvigo, a drug for adult patients suffering from insomnia. Based on two late-stage trials comparing Dayvigo to placebo for up to one month and six months in patients with insomnia, the FDA approved the drug in dosages of 5 mg and 10 mg.

Segmentation of Circadian Rhythm Sleep Treatment Market Research

• By Treatment :

  • Devices
  • Medications
  • Chronotherapy

• By Disorder :

  • Delayed Sleep Phase Syndrome
  • Advanced Sleep Phase Syndrome
  • Non-24-hour Sleep-wake Syndrome
  • Irregular Sleep-wake Disorders
  • Shift Work Disorders
  • Jet Lag

• By Sales Channel :

  • Institutional Sales
  • Retail Sales

• By Region :

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Middle East & Africa